Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05131529 · ClinicalTrials.gov registry record · NA
Reshaping Food Choice at University of Michigan
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 3,003
- Enrollment target
NCT05131529: Completed NA study, sponsored by University of Michigan.
NCT05131529 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 3,003 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05131529, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,003 participants
- Enrollment target
Study Summary
Nearly a quarter of global greenhouse gas emissions originate from agriculture. Consumer demand for food, especially carbon-intensive red meats, largely underlies these emissions. Therefore, reducing consumption of red meat has the potential for transformative impacts on climate change. Our interdisciplinary team of researchers and dining staff aims to determine the carbon impact of evidence-based behavior change interventions to reduce red meat consumption at University of Michigan dining halls. Using an experimental design, we will evaluate the impacts of three "nudge" interventions (i.e., modifying environmental cues and incentives) to reduce red meat consumption in three randomly assigned treatment dining halls vis-à-vis three paired control dining halls. Nudges will include changing default food items and altering food labels. We will: 1) collect data on meals served during each intervention periods to assess the separate and combined effects of the interventions on red meat consumption; 2) conduct e-mail interviews with students to understand treatment effect heterogeneity and sociodemographic determinants of food choice; and, 3) conduct focus group discussions and interviews, respectively, with students and dining staff to assess implementation feasibility. We expect that this research will generate scalable, replicable solutions for reducing greenhouse gas emissions through dietary change at universities and similar institutions, will significantly advance the food choice literature, and will influence sustainability strategies at university dining operations nationally given the proposed team's close partnership with regional and national dining programs.
Primary Outcome
We will assess the amount of red meat served across project dining halls from the the pre-intervention to the intervention period using "post-cost" data collected by operations staff (i.e., the amount of each dish prepared prior to the start of a meal period as well as the amount of each dish remaining at the end of the meal period with units of measure standardized to kg. We will assess the average weight of red meat served in each dining hall during the pre-intervention baseline period compare
Interventions
- OTHER Taste-focused labels
- OTHER Carbon impact labels
- OTHER Changing default menu options
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,003 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2022-12-18 |
| Phase | NA |
What the finished NCT05131529 record still lists
NCT05131529 is an interventional study that assigns participants to a tested intervention. Its 3,003 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 3 interventions - of which Taste-focused labels is the first listed.
NCT05131529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05131529 about?
NCT05131529 is a clinical study titled "Reshaping Food Choice at University of Michigan". Nearly a quarter of global greenhouse gas emissions originate from agriculture. Consumer demand for food, especially carbon-intensive red meats, largely underlies these emissions. Therefore, reducing consumption of red meat has the potential for transformative impacts on climate change. Our interdis...
What is the current status of trial NCT05131529?
This trial is currently completed. It is a NA study. The enrollment target is 3,003 participants. The study started on 2021-08-30. Estimated completion is 2022-12-18.
What interventions are being tested in trial NCT05131529?
The interventions under investigation include: Taste-focused labels (OTHER), Carbon impact labels (OTHER), Changing default menu options (OTHER).
Who is sponsoring clinical trial NCT05131529?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05131529's enrollment target sits among peer trials
3,003 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI